Aggressive surgery is best treatment option for early stage lung cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Patients with early stage lung cancer live longer when they receive a lobectomy rather than a less extensive operation or radiation treatment, according to a study published in The Annals of Thoracic Surgery.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Rybrevant (amivantamab-vmjw) + Lazcluze (lazertinib) demonstrated a statistically significant and clinically meaningful overall survival improvement for patients with previously untreated locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletions or L858R substitution mutations, according to data from the phase III Mariposa study.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login